Activating Compound | Comment | Organism | Structure |
---|---|---|---|
benfotiamine | - |
Rattus norvegicus | |
benfotiamine | not inhibitory on proliferation of insulinoma cell line INS-1. Treatment activates glucose metabolism in INS-1 cells in high-glucose culture conditions and maximizes the cells' ability to synthesize insulin. Treatment activates glucokinase | Rattus norvegicus |
Application | Comment | Organism |
---|---|---|
medicine | treatment of hyperglycemic mice with BM-derived IPCs transplantation and benfotiamine, whereby activation of transketolase by benfotiamine can be playing a significant role in upregulation of both glucose metabolism and insulin protein synthesis | Rattus norvegicus |
pharmacology | benfotiamine treatment activates glucose metabolism in INS-1 cells in high-glucose culture conditions and maximizes the cells' ability to synthesize insulin. Treatment activates glucokinase | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
oxythiamine | inhibitory on proliferation of insulinoma cell line INS-1; when IPCs are cultured with oxythiamine, transketolase activity and insulin gene expression are suppressed | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
bone marrow cell line | adult bone marrow-derived insulin-producing cells, presence of transketolase protein under high-glucose conditions | Rattus norvegicus | - |
INS-1 cell | insulinoma cell line | Rattus norvegicus | - |
INS-1 cell | insulinoma cell line. Proliferation of cells is not inhibited by transketolase inhibitor benfotiamine | Rattus norvegicus | - |
additional information | BM-derived IPC cell, in bone marrow derived insulin-producing cells, transketolase is detectable under high glucose culture conditions | Rattus norvegicus | - |